|
|
||||||||||||||
|
|
|||||||||||||||
a Molecular
Pathology Section, Division of Biomedical Sciences, Imperial College
School of Medicine, South Kensington, London SW7 2AZ, b Rheumatology Unit, City Hospital, Nottingham, c Department
of Veterinary Basic Sciences, The Royal Veterinary College, London
Correspondence to: Professor R M Mason.
Accepted for publication 26 March 1999
OBJECTIVES
To
determine concentrations of chondroitin sulphate (CS) disaccharides in
knee synovial fluid (SF) from normal subjects and patients with
osteoarthritis (OA) or rheumatoid arthritis (RA), to test whether these
variables differ between different diseases and subsets of OA.
METHODS
OA was
subdivided into large joint OA (LJOA), nodal generalised OA (NGOA), and
OA with calcium pyrophosphate crystal deposition (CPA), with 25, 9, and
11 people in each subset respectively. The SF of 13 normal subjects was
also volunteered for analysis along with 15 RA patients. Clinical
assessment of inflammation (0-6) was undertaken on OA and RA knees.
Concentrations of unsaturated CS disaccharides
di6S and
di4S were
measured by capillary zone electrophoresis.
RESULTS
Concentrations
of
di6S were lower in RA (5.90 ng/ml) and OA (13.24 ng/ml) fluids
compared with normal (21.0 ng/ml) but no significant differences were
seen between disease and normal fluids for
di4S (about 4-6 ng/ml).
The ratio of
di6S:
di4S were RA<OA<normal subjects (p<0.001 for
all comparisons). The disaccharide concentration values along with the
ratios are below. Higher
di6S:
di4S ratios were obtained for LJOA
and CPA compared with NGOA. Uninflamed knees had lower concentrations
of
di6S than inflamed knees (p<0.01). In patients with bilateral
samples, there were strong correlations between right and left knees
for all SF variables.
CONCLUSIONS
Altered
ratios of CS sulphation patterns occur in OA and within OA subsets.
These further justify considering NGOA as a subset with a different aetiopathogenesis.
This article has been cited by other articles:
![]() |
P. Pothacharoen, K. Kalayanamitra, S. S. Deepa, S. Fukui, T. Hattori, N. Fukushima, T. Hardingham, P. Kongtawelert, and K. Sugahara Two Related but Distinct Chondroitin Sulfate Mimetope Octasaccharide Sequences Recognized by Monoclonal Antibody WF6 J. Biol. Chem., November 30, 2007; 282(48): 35232 - 35246. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Bathe, G. C. Rutledge, A. J. Grodzinsky, and B. Tidor Osmotic Pressure of Aqueous Chondroitin Sulfate Solution: A Molecular Modeling Investigation Biophys. J., October 1, 2005; 89(4): 2357 - 2371. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Bathe, G. C. Rutledge, A. J. Grodzinsky, and B. Tidor A Coarse-Grained Molecular Model for Glycosaminoglycans: Application to Chondroitin, Chondroitin Sulfate, and Hyaluronic Acid Biophys. J., June 1, 2005; 88(6): 3870 - 3887. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. C Bautch, M. K Clayton, Q. Chu, and K. A Johnson Synovial fluid chondroitin sulphate epitopes 3B3 and 7D4, and glycosaminoglycan in human knee osteoarthritis after exercise Ann Rheum Dis, November 1, 2000; 59(11): 887 - 891. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS | REGISTER |